These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 1322866)

  • 1. Beneficial health effects of modest weight loss.
    Goldstein DJ
    Int J Obes Relat Metab Disord; 1992 Jun; 16(6):397-415. PubMed ID: 1322866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated review on the benefits of weight loss.
    Vidal J
    Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S25-8. PubMed ID: 12457296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of sustained moderate weight loss in obesity.
    Pasanisi F; Contaldo F; de Simone G; Mancini M
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the benefits of moderate weight loss?
    de Leiva A
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():10-3. PubMed ID: 9792475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome success in obesity.
    Klein S
    Obes Res; 2001 Nov; 9 Suppl 4():354S-358S. PubMed ID: 11707565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of reducing--revisited.
    Blackburn GL; Read JL
    Postgrad Med J; 1984; 60 Suppl 3():13-8. PubMed ID: 6240029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
    Mertens IL; Van Gaal LF
    Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus.
    Wing RR
    J Am Diet Assoc; 1995 May; 95(5):569-72; quiz 573-4. PubMed ID: 7722192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
    Bhan V; Yan RT; Leiter LA; Fitchett DH; Langer A; Lonn E; Tan M; Silagy S; Goodman SG; Yan AT;
    Am J Cardiol; 2010 Nov; 106(9):1270-6. PubMed ID: 21029823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the obese patient in primary care: targeting and meeting goals and expectations.
    Bray G; Look M; Ryan D
    Postgrad Med; 2013 Sep; 125(5):67-77. PubMed ID: 24113665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Leiter LA; Abbott D; Campbell NR; Mendelson R; Ogilvie RI; Chockalingam A
    CMAJ; 1999 May; 160(9 Suppl):S7-12. PubMed ID: 10333848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of obesity-related hypertension].
    Skoczylas A
    Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss.
    Vetter ML; Amaro A; Volger S
    Postgrad Med; 2014 Jan; 126(1):139-52. PubMed ID: 24393761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The workinghman's diet. II. Effect of weight reduction in obese patients with hypertension, diabetes, hyperuricemia and hyperlipidemia.
    Heyden S
    Nutr Metab; 1978; 22(3):141-59. PubMed ID: 634508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
    Cheah JS
    Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.
    Caterson ID; Finer N; Coutinho W; Van Gaal LF; Maggioni AP; Torp-Pedersen C; Sharma AM; Legler UF; Shepherd GM; Rode RA; Perdok RJ; Renz CL; James WP;
    Diabetes Obes Metab; 2012 Jun; 14(6):523-30. PubMed ID: 22192338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.